ZA200400289B - Chimeric chains that code for proteins that induce effects directed against viruses. - Google Patents
Chimeric chains that code for proteins that induce effects directed against viruses.Info
- Publication number
- ZA200400289B ZA200400289B ZA200400289A ZA200400289A ZA200400289B ZA 200400289 B ZA200400289 B ZA 200400289B ZA 200400289 A ZA200400289 A ZA 200400289A ZA 200400289 A ZA200400289 A ZA 200400289A ZA 200400289 B ZA200400289 B ZA 200400289B
- Authority
- ZA
- South Africa
- Prior art keywords
- chimeric
- proteins
- serotype
- chimeric chains
- code
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title 1
- 241000725619 Dengue virus Species 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 230000002766 immunoenhancing effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20010172A CU23245A1 (es) | 2001-07-16 | 2001-07-16 | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200400289B true ZA200400289B (en) | 2004-09-12 |
Family
ID=40091633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200400289A ZA200400289B (en) | 2001-07-16 | 2004-01-14 | Chimeric chains that code for proteins that induce effects directed against viruses. |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US7279164B2 (fr) |
| EP (1) | EP1418180B1 (fr) |
| JP (1) | JP4417712B2 (fr) |
| KR (1) | KR100991717B1 (fr) |
| CN (1) | CN100378123C (fr) |
| AT (1) | ATE349466T1 (fr) |
| BR (1) | BR0211178A (fr) |
| CA (1) | CA2453300C (fr) |
| CU (1) | CU23245A1 (fr) |
| DE (1) | DE60217129T2 (fr) |
| DK (1) | DK1418180T3 (fr) |
| ES (1) | ES2278041T3 (fr) |
| GT (1) | GT200200150A (fr) |
| MX (1) | MXPA04000486A (fr) |
| MY (1) | MY138482A (fr) |
| PT (1) | PT1418180E (fr) |
| WO (1) | WO2003008571A2 (fr) |
| ZA (1) | ZA200400289B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| CU23578A1 (es) * | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
| CU23586A1 (es) | 2005-11-22 | 2010-10-30 | Ct Ingenieria Genetica Biotech | Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus |
| CU23630A1 (es) | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
| CU20080028A6 (es) * | 2008-02-29 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus |
| EP2632485A4 (fr) * | 2010-10-29 | 2014-05-28 | Merck Sharp & Dohme | Vaccin à sous-unité recombinante contre le virus de la dengue |
| CU24188B1 (es) * | 2012-12-27 | 2016-07-29 | Ct De Ingeniería Genética Y Biotecnología | Composición vacunal contra el virus dengue |
| ITRM20130458A1 (it) * | 2013-08-05 | 2015-02-05 | Internat Ct For Genetic En Gineering And | Vaccino genetico anti-dengue virus basato sugli ectodomini della proteina envelope |
| CN113429479B (zh) * | 2018-04-04 | 2023-03-10 | 中国科学院微生物研究所 | 一种高灵敏度的黄热病毒人源单克隆抗体及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22302A1 (es) * | 1990-09-07 | 1995-01-31 | Cigb | Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales |
| ES2153223T3 (es) | 1991-09-19 | 2001-02-16 | Us Health | Flavivirus quimericos y/o flavivirus de crecimiento restringido. |
| CA2224724C (fr) * | 1995-05-24 | 2007-12-04 | Hawaii Biotechnology Group, Inc. | Vaccin purifie contre une infection par flavivirus |
| CU22559A1 (es) | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
| WO1997043310A1 (fr) | 1996-05-10 | 1997-11-20 | Schering Corporation | Inhibiteurs synthetiques de la protease ns3 du virus de l'hepatite c |
| CU22666A1 (es) | 1996-11-25 | 2001-04-27 | Inst De Medicina Tropical Pedro Kouri | Procedimiento para la expresión de genes de los virus del dengue en la levadura pichia pastoris, adns recombinantes y microorganismos transformados |
| CU22683A1 (es) * | 1997-01-15 | 2001-07-20 | Inst De Medicina Tropical Pedro Kouri | Epítopes de la proteína pre-m/m del virus del dengue, péptidos sintéticos, proteínas quiméricas y sus usos |
| ES2241157T3 (es) | 1997-08-11 | 2005-10-16 | Boehringer Ingelheim (Canada) Ltd. | Peptidos inhibidores de la hepatitis c. |
| DE69833002T2 (de) | 1997-10-08 | 2006-08-24 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Chimärer impfstoff gegen das zeckenenzephalitis virus |
| BR0010361A (pt) | 1999-04-30 | 2003-06-10 | Chiron Corp | Seq ências genÈmicas de neisseria e uso destas |
| CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| AU2003239932A1 (en) * | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| WO2004052293A2 (fr) | 2002-12-11 | 2004-06-24 | Hawaii Biotech, Inc. | Vaccin de recombinaison contre l'infection a flavivirus |
| EP1454988A1 (fr) | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Pseudo-particules du flavivirus infectieuses contenant des protéines prM-E d'enveloppe |
| WO2005002501A2 (fr) | 2003-04-22 | 2005-01-13 | Children's Medical Center Corporation | Nouvelles regions cibles pour des medicaments dans la glycoproteine d'enveloppe du virus de la dengue et procedes d'utilisation associes |
| MY157941A (en) | 2005-01-19 | 2016-08-15 | Vaxinnate Corp | Compositions of pathogen-associated molecular patterns and methods of use |
| CA2508266A1 (fr) | 2005-06-20 | 2006-12-20 | Institut Pasteur | Polypeptides chimeriques et leurs applications therapeutiques contre une infection a flaviviridae |
| CU23632A1 (es) | 2006-04-28 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Métodos para la identificación de candidatos terapéuticos contra enfermedades causadas por flavivirus y moléculas antivirales. |
-
2001
- 2001-07-16 CU CU20010172A patent/CU23245A1/es unknown
-
2002
- 2002-07-10 MY MYPI20022623A patent/MY138482A/en unknown
- 2002-07-12 KR KR1020047000610A patent/KR100991717B1/ko not_active IP Right Cessation
- 2002-07-12 US US10/484,114 patent/US7279164B2/en not_active Expired - Fee Related
- 2002-07-12 JP JP2003514888A patent/JP4417712B2/ja not_active Expired - Fee Related
- 2002-07-12 WO PCT/CU2002/000006 patent/WO2003008571A2/fr active IP Right Grant
- 2002-07-12 GT GT200200150A patent/GT200200150A/es unknown
- 2002-07-12 AT AT02760073T patent/ATE349466T1/de not_active IP Right Cessation
- 2002-07-12 EP EP02760073A patent/EP1418180B1/fr not_active Expired - Lifetime
- 2002-07-12 BR BR0211178-0A patent/BR0211178A/pt not_active IP Right Cessation
- 2002-07-12 DE DE60217129T patent/DE60217129T2/de not_active Expired - Lifetime
- 2002-07-12 CA CA2453300A patent/CA2453300C/fr not_active Expired - Fee Related
- 2002-07-12 CN CNB028143507A patent/CN100378123C/zh not_active Expired - Fee Related
- 2002-07-12 ES ES02760073T patent/ES2278041T3/es not_active Expired - Lifetime
- 2002-07-12 MX MXPA04000486A patent/MXPA04000486A/es active IP Right Grant
- 2002-07-12 DK DK02760073T patent/DK1418180T3/da active
- 2002-07-12 PT PT02760073T patent/PT1418180E/pt unknown
-
2004
- 2004-01-14 ZA ZA200400289A patent/ZA200400289B/xx unknown
-
2007
- 2007-02-13 US US11/705,696 patent/US7566457B2/en not_active Expired - Fee Related
-
2009
- 2009-06-12 US US12/483,607 patent/US7947281B2/en not_active Expired - Fee Related
-
2011
- 2011-04-26 US US13/094,287 patent/US8105606B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8105606B2 (en) | 2012-01-31 |
| US7566457B2 (en) | 2009-07-28 |
| US20070141081A1 (en) | 2007-06-21 |
| PT1418180E (pt) | 2007-04-30 |
| US20110200628A1 (en) | 2011-08-18 |
| EP1418180B1 (fr) | 2006-12-27 |
| ES2278041T3 (es) | 2007-08-01 |
| US20040234951A1 (en) | 2004-11-25 |
| KR100991717B1 (ko) | 2010-11-03 |
| US7279164B2 (en) | 2007-10-09 |
| CU23245A1 (es) | 2007-10-17 |
| US20090274718A1 (en) | 2009-11-05 |
| DE60217129D1 (de) | 2007-02-08 |
| ATE349466T1 (de) | 2007-01-15 |
| CA2453300C (fr) | 2012-03-20 |
| MY138482A (en) | 2009-06-30 |
| CN1531548A (zh) | 2004-09-22 |
| JP2004537306A (ja) | 2004-12-16 |
| GT200200150A (es) | 2003-06-19 |
| EP1418180A2 (fr) | 2004-05-12 |
| WO2003008571A9 (fr) | 2004-04-15 |
| MXPA04000486A (es) | 2005-03-07 |
| DK1418180T3 (da) | 2007-05-07 |
| WO2003008571A3 (fr) | 2004-03-04 |
| CN100378123C (zh) | 2008-04-02 |
| DE60217129T2 (de) | 2007-10-31 |
| CA2453300A1 (fr) | 2003-01-30 |
| US7947281B2 (en) | 2011-05-24 |
| BR0211178A (pt) | 2004-08-10 |
| WO2003008571A2 (fr) | 2003-01-30 |
| JP4417712B2 (ja) | 2010-02-17 |
| KR20040030056A (ko) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002012281A3 (fr) | Vaccin moleculaire liant un polypeptide chaperon du reticulum endoplasmique a un antigene | |
| AU2003290985B2 (en) | West nile virus vaccine | |
| WO2003048184A3 (fr) | Vaccin a sous-unite de ns1 de flavivirus | |
| ATE526411T1 (de) | Avirulente, immunogene flavivirus-chimäre | |
| DE60234375D1 (de) | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG | |
| MXPA05009289A (es) | Conjugados de particulas tipo virus del analogo del peptido melan-a. | |
| WO2002080851A3 (fr) | Vaccins chimeriques | |
| DE69231570D1 (de) | Chimäre und/oder wachstumgehemmte Flaviviren | |
| CA2158455A1 (fr) | Chimeres immunogenes comportant des sequences d'acides nucleiques codant pour les peptides de la sequence du signal du reticule endoplasmique et au moins un autre peptide, et leurs ustilisations dans les vaccins et le traitement des maladies | |
| WO2007149715A3 (fr) | Nouvelles séquences d'adn, vecteurs, protéines et utilisation de l'hémagglutinine de la grippe aviaire | |
| DK0783321T3 (da) | VR-2332 viral nucleotidsekvens og fremgangsmåder til anvendelse | |
| WO2002061113A3 (fr) | Vaccin moleculaire superieur a base d'arn autoreplicatif, d'adn suicide ou de vecteur d'adn nu, qui lie un antigene a un polypeptide qui favorise la presentation de l'antigene | |
| WO2004085633A8 (fr) | Nouveau virus humain provoquant le syndrome respiratoire aigu severe (sars) et son utilisation | |
| ZA200400289B (en) | Chimeric chains that code for proteins that induce effects directed against viruses. | |
| WO2005081716A3 (fr) | Vaccins adn ciblant des antigenes du coronavirus du syndrome respiratoire aigu severe (sars-cov) | |
| WO2002095023A3 (fr) | Replicons derives de genomes viraux a arn brin positif utilises dans la production de proteines heterologues | |
| ZA945275B (en) | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor | |
| EP1613345A4 (fr) | Compositions contenant un virus syncytial respiratoire de la souche 9320 du sous-groupe b, et procedes associes | |
| Xue et al. | Molecular engineering tools for the development of vaccines against infectious diseases: current status and future directions | |
| JP2011120598A (ja) | Ｈｌａ結合性ペプチド、それをコードするｄｎａ断片および組み換えベクター | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| WO2001049712A3 (fr) | Vaccin destine a la prevention et/ou la prophylaxie de l'anemie infectieuse du saumon chez des poissons | |
| WO2002038769A3 (fr) | Sequences adn expressionnelles codant pour hpv 16-l1 et hpv 16-l2 optimises eukaryotiques | |
| BR9508645A (pt) | Vacina da peritonite infecciosa felina | |
| AU2018200081B2 (en) | Avirulent, immunogenic flavivirus chimeras |